MedImmune Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MedImmune

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Shlepper who wrote (52)	6/5/1997 3:15:00 PM
From: Pseudo Biologist	of 416

Haven't been able to find anything substantial. MEDI is mentioned in the press release from Human Genome Sciences regarding their recent deal with the state of Maryland for building a manufacturing plant for biologics. Merril Lynch had a price target of $17 not long ago based on a 60/40 scenario for the success of MEDI-493 (the anti-RSV humanized monoclonal); maybe they've changed their mind about the odds? There was a blurb in Time regarding a vaccine agains urinary tract infections (paper in Journal of Urology), but this has nothing to do with MEDI's work (re. Science paper last April); in fact it is a rather low-tech approach using heat-inactivated bugs. Wondering in SFBA, Max

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next